- India has reported a record spike in new cases for seven days in a row
- A ban on travelers from Brazil entering the US is to come into force late Tuesday
- European countries are easing lockdown measures as they gear up for the summer holidays
- Several German states will hold Tuesday meetings to discuss changes to their restrictions
- More than 5.4 million cases have been recorded globally and at least 346,000 people have died from COVID-19
08:09 For the seventh day in a row, India has reported a record spike in the number of coronavirus cases. The country’s health ministry reported 145,380 total confirmed infections as of Tuesday, up 6,535 from the day before. The death toll currently stands at 4,167. The recovery rate has also risen above 40%, officials said.
The majority of cases are concentrated in the neighboring states of Maharashtra and Gujarat in central India. An uptick in infections has also been seen in some of the country’s poorest eastern states, where migrant workers have returned to their native villages from India’s largest cities after lockdown restrictions put many out of work.
The number of coronavirus cases in India has inceased as lockdown measures have been eased. A small number of domestic flights resumed in India on Monday after a two-month hiatus.
07:40 Glenmark Pharmaceuticals Ltd has said it will start a new clinical trial in India to test a combination of the anti-viral drugs favipiravir and umifenovir as a potential cure for COVID-19.
The study aims to enroll 158 hospitalized patients with moderate COVID-19 infections in India, the company said.
Favipiravir was approved for use as an anti-flu drug in Japan in 2014. Umifenovir is licensed as a treatment for some types of flu infections in China and Russia.
0 Comments